How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Gastrointestinal Vibrating Capsule Market
- By Product Type: Single-use Vibrating Capsules, Rechargeable Vibrating Capsules, Programmable Vibrating Capsules
- By Indication: Chronic Constipation, Irritable Bowel Syndrome (IBS), Gastroparesis, Functional Dyspepsia
- By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings
- By Technology: Electromechanical Vibration, Magnetic Vibration, Piezoelectric Vibration
- By Distribution Channel: Direct Sales, Online Pharmacies, Retail Pharmacies, Hospital Procurement
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Single-use Vibrating Capsules leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Gastrointestinal Vibrating Capsule Market report
A complete, evidence-based study - 12 chapters and 117 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Product Type 3
Indication 4
End User 4
Technology 3
Distribution Channel 4
Companies profiled
Medigus Ltd.
Vibrant Ltd.
EnteroMedics Inc.
IntraLuminal Therapeutics Inc.
Motus GI Holdings Inc.
Innovative Health Solutions Inc.
GI Dynamics Inc.
Aspire Bariatrics Inc.
EndoStim Inc.
ReShape Lifesciences
Inc.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medigus Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Vibrant Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →EnteroMedics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →IntraLuminal Therapeutics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Motus GI Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Innovative Health Solutions Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →GI Dynamics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Aspire Bariatrics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →EndoStim Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →ReShape Lifesciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,801M by 2033 · 10.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Single-use Vibrating Capsules46.8
- Rechargeable Vibrating Capsules17.1
- Programmable Vibrating Capsules36.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$723.9M → $1,682M · 11.1%
Europe$504.5M → $1,102M · 10.3%
Asia Pacific$460.7M → $1,127M · 11.8%
Latin America$285.2M → $611.0M · 10.0%
Middle East and Africa$219.4M → $451.6M · 9.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.242026
10.262027
10.272028
10.282029
10.292030
10.292031
10.322032
10.332033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medigus Ltd.22.9
- Vibrant Ltd.14.4
- EnteroMedics Inc.7.2
- IntraLuminal Therapeutics Inc.11.9
- Motus GI Holdings Inc.9.4
- Innovative Health Solutions Inc.6.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type25.6%
Indication14.0%
End User20.5%
Technology27.3%
Distribution Channel12.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.8
- Europe22.2
- Asia Pacific22.7
- Latin America12.3
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medigus Ltd. | 79 | 85 | 89 | 87 | 86 | 95 | 87 |
| Vibrant Ltd. | 75 | 86 | 85 | 91 | 81 | 75 | 82 |
| EnteroMedics Inc. | 73 | 67 | 74 | 75 | 79 | 68 | 73 |
| IntraLuminal Therapeutics Inc. | 66 | 66 | 78 | 80 | 58 | 81 | 72 |
| Motus GI Holdings Inc. | 65 | 65 | 71 | 65 | 69 | 69 | 67 |
| Innovative Health Solutions Inc. | 48 | 54 | 63 | 51 | 71 | 52 | 57 |
| GI Dynamics Inc. | 49 | 55 | 64 | 55 | 59 | 59 | 57 |
| Aspire Bariatrics Inc. | 45 | 37 | 43 | 54 | 54 | 46 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medigus Ltd.
- Vibrant Ltd.
- EnteroMedics Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medigus Ltd. | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Vibrant Ltd. | ✓ | ✓ | ◐ | ✓ | ✓ | − |
| EnteroMedics Inc. | − | ✓ | ✓ | ◐ | ✓ | − |
| IntraLuminal Therapeutics Inc. | − | − | ◐ | ✓ | ◐ | ✓ |
| Motus GI Holdings Inc. | ◐ | − | ✓ | − | − | ✓ |
| Innovative Health Solutions Inc. | ◐ | − | ✓ | − | ◐ | − |
| GI Dynamics Inc. | − | − | ◐ | ◐ | ◐ | ◐ |
| Aspire Bariatrics Inc. | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medigus Ltd.87
2Vibrant Ltd.82
3EnteroMedics Inc.73
4IntraLuminal Therapeutics Inc.72
5Motus GI Holdings Inc.67
6Innovative Health Solutions Inc.57
7GI Dynamics Inc.57
8Aspire Bariatrics Inc.47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Medigus Ltd.Vibrant Ltd.
Challenger3
Strong scale, closing on the leaders.
EnteroMedics Inc.IntraLuminal Therapeutics Inc.Motus GI Holdings Inc.
Contender2
Focused players with pockets of strength.
Innovative Health Solutions Inc.GI Dynamics Inc.
Niche1
Specialists in a single segment or region.
Aspire Bariatrics Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Gastrointestinal Vibrating Capsule Market — a $624M beachhead inside a $8.08B market.
Beachhead (SOM)$624Mobtainable near-term
Serviceable (SAM)$3.31Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Single-use Vibrating Capsules
Best fit — highest urgency & budget in Product Type.
Economic buyer79 fit
Rechargeable Vibrating Capsules
Strong fit — clear ROI and a fast path to value.
End user69 fit
Programmable Vibrating Capsules
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Indication & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Gastrointestinal Vibrating Capsule Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation12%
Closed-won8%
$16.4KCAC
$71KLTV
4.3:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Gastrointestinal Vibrating Capsule Market is a resilient opportunity — $7.47B by 2033, compounding at 4.1%.
TAM · 2025$5.41Btoday
TAM · 2033$7.47Bforecast
CAGR4.1%2027–2033
Cumulative$57.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.47BTotal addressable market
SAM$2.67BServiceable available market
SOM$485MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.47BLarge & growingTAM by 2033 at 4.1% CAGR
$2.67BServiceable nowreachable with today’s model
$485MBeachhead winobtainable near-term share
11+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.83BBear2.7% CAGR
$7.47BBase4.1% CAGR
$9.56BBull5.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Indication optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Gastrointestinal Vibrating Capsule Market — a $6.65B market by 2033. Plan: grow share from 8.2% to 16.7%.
Market size · 2033$6.65Btotal addressable
Market CAGR11.4%2027–2033
Target share16.7%from 8.2% today
Revenue ambition$1.11Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.2% | 16.7% | On track |
| Revenue | $526M | $1.11B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 37.5% | 42.4% | On track |
| Customer retention | 88.7% | 96.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Indication capability
A defensible second engine — invest in Indication to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Indication
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $140M capacity & capability investment
- Greenlight bolt-on M&A in Indication
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Gastrointestinal Vibrating Capsule Market conversation — a $2.23B market you can size, segment and defend in minutes.
Market size · 2033$2.23Btotal opportunity
Growth6.8%CAGR to 2033
Addressable buyers1,339+accounts in scope
Typical ROI6.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.4×return on cost, year one
< 3 mopayback period
$60K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
11+players profiled in this market
Coverage includes
Medigus Ltd.Vibrant Ltd.EnteroMedics Inc.IntraLuminal Therapeutics Inc.Motus GI Holdings Inc.Innovative Health Solutions Inc.GI Dynamics Inc.Aspire Bariatrics Inc.+3 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Gastrointestinal Vibrating Capsule Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Gastrointestinal Vibrating Capsule Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Gastrointestinal Treatment Ozone Therapy Unit Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportGastrointestinal Testing Panel Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportGastrointestinal Suturing Device Market
Market size, share, segmentation and regional forecast.
$459M market · 2025 base year
View reportGastrointestinal Surgery Suture Thread Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportGastrointestinal Surgery Staplers Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportGastrointestinal Stromal Tumors Therapeutics Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportGastrointestinal Stromal Tumors (GSTs) Treatment Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportGastrointestinal Rare Diseases Treatment Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportGastrointestinal Radiofrequency Ablation Systems Market
Market size, share, segmentation and regional forecast.
$870M market · 2025 base year
View reportGastrointestinal Pathogen Testing Kits Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportGastrointestinal Pathogens Panels Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportGastrointestinal Motivity Marker Capsule Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.